Cardiology Fiesta
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition
By
Cardiology Fiesta 2017
FEATURING
Ralph DeFronzo
By
Cardiology Fiesta 2017
FEATURING
Ralph DeFronzo
Login to view comments.
Click here to Login
SESSION II | Optimizing Therapy for Heart Failure